Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK1 | P06493 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.41 |
| ▸ | YTHDC1 | Q96MU7 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10077231 | 0.89 | TSHR (0.43) | CDK1HDAC1HDAC2NPC1RAB9A | |
| SCHEMBL10077227 | 0.89 | HTT (0.43) | CDK1HDAC1HDAC2HDAC8YTHDC1 | |
| SCHEMBL7852208 | 0.88 | HDAC1 (0.43) | CDK1HDAC1HDAC2NPC1RAB9A | |
| SCHEMBL13074308 | 0.88 | CDK1 (0.42) | CDK1HDAC1HDAC2NPC1RAB9A | |
| SCHEMBL3130095 | 0.84 | TDP1 (0.48) | HDAC1HDAC2NPC1RAB9APOLB | |
| SCHEMBL27586664 | 0.82 | CDK1 (0.45) | CDK1HDAC1HDAC2NPC1RAB9A | |
| SCHEMBL2153643 | 0.80 | MGMT (0.54) | CDK1HDAC1HDAC2ALDH1A1CYP1A2 | |
| SCHEMBL432837 | 0.80 | CCNE2 (0.37) | CDK1HDAC1HDAC2NPC1RAB9A | |
| SCHEMBL430210 | 0.80 | CCNE2 (0.38) | CDK1HDAC1HDAC2POLBHDAC3 | |
| SCHEMBL10077226 | 0.80 | HTT (0.41) | CDK1HDAC1HDAC2NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130231480-A1 | SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF | GENEARREST LTD (IL) | 2013-09-05 | — | — | US | disclosed |
| US-20130231480-A1 | SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF | GENEARREST LTD (IL) | 2013-09-05 | — | — | US | disclosed |
| US-20130231480-A1 | SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF | GENEARREST LTD (IL) | 2013-09-05 | — | — | US | disclosed |
| EP-2596102-A2 | SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF | GeneArrest Ltd (IL) | 2013-05-29 | — | — | EP | disclosed |
| WO-2012011114-A2 | SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF | GENEARREST LTD (IL) | 2012-01-26 | — | — | WO | disclosed |
| WO-2012011114-A2 | SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF | GENEARREST LTD (IL) | 2012-01-26 | — | — | WO | disclosed |
| US-20100284959-A1 | SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF | GENE ARREST LTD. (IL) | 2010-11-11 | — | — | US | disclosed |
| US-20100284959-A1 | SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF | GENE ARREST LTD. (IL) | 2010-11-11 | — | — | US | disclosed |
| US-20100284959-A1 | SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF | GENE ARREST LTD. (IL) | 2010-11-11 | — | — | US | disclosed |
| EP-1381392-A4 | SYNTHETIC CATALYST FOR SELECTIVE CLEAVAGE OF PROTEIN AND METHOD FOR SELECTIVE CLEAVAGE OF PROTEIN USING THE SAME | TS CORP (KR) | 2005-03-23 | — | — | EP | disclosed |
| CN-1531444-A | Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using same | ������������ʽ���� | 2004-09-22 | — | — | CN | disclosed |
| EP-1381392-A1 | SYNTHETIC CATALYST FOR SELECTIVE CLEAVAGE OF PROTEIN AND METHOD FOR SELECTIVE CLEAVAGE OF PROTEIN USING THE SAME | TS Corporation (KR) | 2004-01-21 | — | — | EP | disclosed |
| US-6613873-B1 | Covalently bound to a polyamide backbone; given formula; exhibit increased sequence specificity and binding affinity; resistant to enzyme degradation | ISIS PHARMACEUTICALS, INC. | 2003-09-02 | — | — | US | disclosed |
| US-20020165365-A1 | Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same | ARTZYME BIOTECH CORPORATION (KR) | 2002-11-07 | — | — | US | disclosed |
| WO-2002085413-A1 | SYNTHETIC CATALYST FOR SELECTIVE CLEAVAGE OF PROTEIN AND METHOD FOR SELECTIVE CLEAVAGE OF PROTEIN USING THE SAME | TS CORPORATION (KR) | 2002-10-31 | — | — | WO | disclosed |
| US-20020146718-A1 | Peptide nucleic acids having 2,6-diaminopurine nucleobases | BUCHARDT OLE (DK) | 2002-10-10 | — | — | US | disclosed |
| US-6414112-B1 | BIND COMPLEMENTARY NUCLEIC ACIDS MORE STRONGLY AND HAVE INCREASED SEQUENCE SPECIFICITY AND BINDING AFFINITY | BUCHARDT OLE (DE) | 2002-07-02 | — | — | US | disclosed |
| US-5766855-A | Peptide nucleic acids having enhanced binding affinity and sequence specificity | BUCHARDT OLE (DK) | 1998-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100284959-A1 | SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF | POLRMT, POLM, SNRPE | CDK1 3891/4885HDAC1 2698/4885HDAC2 2623/4885 |
| US-20020146718-A1 | Peptide nucleic acids having 2,6-diaminopurine nucleobases | NT5C3B, NSUN2, PCNA | CDK1 2635/4885HDAC1 3254/4885HDAC2 3251/4885 |
| US-20130231480-A1 | SEQUENCE SPECIFIC DOUBLE-STRANDED DNA/RNA BINDING COMPOUNDS AND USES THEREOF | POLM, POLRMT, DDB1 | CDK1 3897/4885HDAC1 2773/4885HDAC2 2568/4885 |
| US-20020165365-A1 | Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same | CPN1, RNPEP, ANPEP | CDK1 2834/4885HDAC1 2769/4885HDAC2 3647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.